Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

No Description
MEDICAL ACTION INDUSTRIES INC.
70916K
Not in Commercial Distribution

  • 20809160188757 ()
  • 10809160188750 ()


  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
77846
Not in Commercial Distribution

  • 20809160172374 ()
  • 10809160172377 ()


  • Vascular access device flush/disinfection tool
Kit Port Disposable/sngle Use Fda Class Ii Not Nat Rubber Ltx MediChoice
OWENS & MINOR DISTRIBUTION, INC.
PA1012
In Commercial Distribution

  • 20885632147033 ()
  • 10885632147036 ()


  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
76259
Not in Commercial Distribution

  • 20809160121495 ()
  • 10809160121498 ()


  • Vascular access device flush/disinfection tool
48653 HYH,PREFILLSYR,SALINE SFR,CLEAR,10ML,240
O&M HALYARD, INC.
48653
In Commercial Distribution

  • 20680651486534 ()
  • 10680651486537 ()
  • 30680651486531 ()
  • 90680651486533 ()
48653

  • Vascular access device flush/disinfection tool
48652 HYH,PREFILLSYR,SALINE,CLEAR,3ML,480
O&M HALYARD, INC.
48652
In Commercial Distribution

  • 20680651486527 ()
  • 10680651486520 ()
  • 30680651486524 ()
  • 90680651486526 ()
48652

  • Vascular access device flush/disinfection tool
48651 HYH,PREFILLSYR,SALINE,CLEAR,5ML,480
O&M HALYARD, INC.
48651
In Commercial Distribution

  • 30680651486517 ()
  • 20680651486510 ()
  • 10680651486513 ()
  • 90680651486519 ()
48651

  • Vascular access device flush/disinfection tool
48650 HYH,PREFILLSYR,SALINE,CLEAR,10ML,480
O&M HALYARD, INC.
48650
In Commercial Distribution

  • 20680651486503 ()
  • 10680651486506 ()
  • 30680651486500 ()
  • 90680651486502 ()
48650

  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
76930
Not in Commercial Distribution

  • 20809160140434 ()
  • 10809160140437 ()


  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
76954
Not in Commercial Distribution

  • 20809160140427 ()
  • 10809160140420 ()


  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
76931
Not in Commercial Distribution

  • 20809160140410 ()
  • 10809160140413 ()


  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
76060
Not in Commercial Distribution

  • 20809160132088 ()
  • 10809160132081 ()


  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
80630
Not in Commercial Distribution

  • 20809160137489 ()
  • 10809160137482 ()


  • Vascular access device flush/disinfection tool
No Description
MEDICAL ACTION INDUSTRIES INC.
80628
Not in Commercial Distribution

  • 20809160137243 ()
  • 10809160137246 ()


  • Vascular access device flush/disinfection tool
*Custom* Curaplex IV Flush Kit
BOUND TREE MEDICAL, LLC
8600-01509
In Commercial Distribution

  • 00810094574772 ()
  • 00810094575540 ()
8600-01509

  • Vascular access device flush/disinfection tool
3M™ Curos™ Disinfecting Cap Strip for Needleless Connectors, 5 cap/strip, 50 strip/carton, 20 carton/case, 5000 cap/case CFF10-250
3M COMPANY
CFF10-250
In Commercial Distribution

  • 50707387786521 ()
  • 30707387786527 ()
  • 00070738778526 ()
CFF10-250

  • Luer-formatted disinfection cap
3M™ Curos™ open female luer cap teal 270/Carton 8 Cartons/Case CSV1-270
3M COMPANY
CSVI-270
In Commercial Distribution

  • 50707387781014 ()
  • 30707387781010 ()
  • 00707387781019 ()
CSVI-270

  • Luer-formatted disinfection cap
CM5-200BNS BULK NON STERILE TIPS
3M COMPANY
CM5-200BNS
In Commercial Distribution

  • 50707387773866 ()
  • 30707387773862 ()
  • 00707387773861 ()
CM5-200BNS

  • Luer-formatted disinfection cap
3M™ Curos™ Jet™ Disinfecting Cap for Needleless Connectors 270/Carton 20 Cartons/Case CFJ1-270
3M COMPANY
CFJ1-270
In Commercial Distribution

  • 50707387773828 ()
  • 30707387773824 ()
  • 00707387773823 ()
CFJ1-270

  • Luer-formatted disinfection cap
3M™ Curos™ Disinfecting Cap for Tego® Hemodialysis Connectors US - CTG1- 270
3M COMPANY
CTG1-270
In Commercial Distribution

  • 50707387773811 ()
  • 30707387773817 ()
  • 00707387773816 ()
CTG1-270

  • Luer-formatted disinfection cap
3M™ Curos™ Tips™ Disinfecting Cap Strip for Male Luers US - CM5-200
3M COMPANY
CM5-200
In Commercial Distribution

  • 50707387773798 ()
  • 30707387773794 ()
  • 00707387773793 ()
CM5-200

  • Luer-formatted disinfection cap
3M™ Curos™ Disinfecting Cap Strip for Needleless Connectors US - CFF10- 250
3M COMPANY
CFF10-250
In Commercial Distribution

  • 50707387773774 ()
  • 30707387773770 ()
  • 00707387773779 ()
CFF10-250

  • Luer-formatted disinfection cap
3M™ Curos™ Disinfecting Cap for Needleless Connectors 270/Carton 20 Cartons/Case CFF1-270
3M COMPANY
CFF1-270
In Commercial Distribution

  • 50707387773750 ()
  • 30707387773756 ()
  • 00707387773779 ()
CFF1-270

  • Luer-formatted disinfection cap
ClearGuard HD end caps are blood access device accessories. The ClearGuard Hemodialysis (HD) end cap is a male luer lock end cap with the antimicrobial agent chlorhexidine acetate on the rod and lock ring threads. Each package contains two ClearGuard HD end caps assembled in a shield. The total amount of chlorhexidine acetate on a pair of devices is not more than 2.4 mg, and the maximum amount that is available to be released to the patient is 0.6 mg per device pair. The ClearGuard HD end caps can be used for up to a maximum of 72 hours. ClearGuard HD is indicated for use as an end cap for use with hemodialysis catheter hubs.The antimicrobial treatment on the ClearGuard HD end cap has been shown to be effective at reducing microbial colonization in hemodialysis catheter hubs against the following microorganisms: Enterococcus faecium (VRE), Enterococcus faecalis (VRE), Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus (MRSA), Staphylococcus aureus, Staphylococcus epidermidis (MRSE), Pseudomonas aeruginosa, Candida albicans and Candida parapsilosis and has not been shown to be effective against Candida paratropicalis and Klebsiella pneumoniae. The antimicrobial effectiveness was evaluated using in vitro methods, and correlation between in vitro antibacterial activity and any clinical effectiveness has not been tested. The subject device is not intended to be used for the treatment of existing infections. The antimicrobial is only effective within the hub of the catheter, and does not migrate to distal portions of the catheter.
Pursuit Vascular, Inc.
CGHD
Not in Commercial Distribution

  • B081CGHD110236865 ()


  • Luer-formatted disinfection cap
ClearGuard HD end caps are blood access device accessories. The ClearGuard Hemodialysis (HD) end cap is a male luer lock end cap with the antimicrobial agent chlorhexidine acetate on the rod and lock ring threads. Each package contains two ClearGuard HD end caps assembled in a shield. The total amount of chlorhexidine acetate on a pair of devices is not more than 2.4 mg, and the maximum amount that is available to be released to the patient is 0.6 mg per device pair. The ClearGuard HD end caps can be used for up to a maximum of 72 hours. ClearGuard HD is indicated for use as an end cap for use with hemodialysis catheter hubs.The antimicrobial treatment on the ClearGuard HD end cap has been shown to be effective at reducing microbial colonization in hemodialysis catheter hubs against the following microorganisms: Enterococcus faecium (VRE), Enterococcus faecalis (VRE), Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus (MRSA), Staphylococcus aureus, Staphylococcus epidermidis (MRSE), Pseudomonas aeruginosa, Candida albicans and Candida parapsilosis and has not been shown to be effective against Candida paratropicalis and Klebsiella pneumoniae. The antimicrobial effectiveness was evaluated using in vitro methods, and correlation between in vitro antibacterial activity and any clinical effectiveness has not been tested. The subject device is not intended to be used for the treatment of existing infections. The antimicrobial is only effective within the hub of the catheter, and does not migrate to distal portions of the catheter.
Pursuit Vascular, Inc.
CGHD
Not in Commercial Distribution

  • B081CGHD110236864 ()


  • Luer-formatted disinfection cap
ClearGuard HD end caps are blood access device accessories. The ClearGuard Hemodialysis (HD) end cap is a male luer lock end cap with the antimicrobial agent chlorhexidine acetate on the rod and lock ring threads. Each package contains two ClearGuard HD end caps assembled in a shield. The total amount of chlorhexidine acetate on a pair of devices is not more than 2.4 mg, and the maximum amount that is available to be released to the patient is 0.6 mg per device pair. The ClearGuard HD end caps can be used for up to a maximum of 72 hours. ClearGuard HD is indicated for use as an end cap for use with hemodialysis catheter hubs.The antimicrobial treatment on the ClearGuard HD end cap has been shown to be effective at reducing microbial colonization in hemodialysis catheter hubs against the following microorganisms: Enterococcus faecium (VRE), Enterococcus faecalis (VRE), Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus (MRSA), Staphylococcus aureus, Staphylococcus epidermidis (MRSE), Pseudomonas aeruginosa, Candida albicans and Candida parapsilosis and has not been shown to be effective against Candida paratropicalis and Klebsiella pneumoniae. The antimicrobial effectiveness was evaluated using in vitro methods, and correlation between in vitro antibacterial activity and any clinical effectiveness has not been tested. The subject device is not intended to be used for the treatment of existing infections. The antimicrobial is only effective within the hub of the catheter, and does not migrate to distal portions of the catheter.
Pursuit Vascular, Inc.
CGHD
Not in Commercial Distribution

  • B081CGHD110236863 ()


  • Luer-formatted disinfection cap
ClearGuard HD end caps are blood access device accessories. The ClearGuard Hemodialysis (HD) end cap is a male luer lock end cap with the antimicrobial agent chlorhexidine acetate on the rod and lock ring threads. Each package contains two ClearGuard HD end caps assembled in a shield. The total amount of chlorhexidine acetate on a pair of devices is not more than 2.4 mg, and the maximum amount that is available to be released to the patient is 0.6 mg per device pair. The ClearGuard HD end caps can be used for up to a maximum of 72 hours. ClearGuard HD is indicated for use as an end cap for use with hemodialysis catheter hubs.The antimicrobial treatment on the ClearGuard HD end cap has been shown to be effective at reducing microbial colonization in hemodialysis catheter hubs against the following microorganisms: Enterococcus faecium (VRE), Enterococcus faecalis (VRE), Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus (MRSA), Staphylococcus aureus, Staphylococcus epidermidis (MRSE), Pseudomonas aeruginosa, Candida albicans and Candida parapsilosis and has not been shown to be effective against Candida paratropicalis and Klebsiella pneumoniae. The antimicrobial effectiveness was evaluated using in vitro methods, and correlation between in vitro antibacterial activity and any clinical effectiveness has not been tested. The subject device is not intended to be used for the treatment of existing infections. The antimicrobial is only effective within the hub of the catheter, and does not migrate to distal portions of the catheter.
Pursuit Vascular, Inc.
CGHD
Not in Commercial Distribution

  • B081CGHD110236862 ()


  • Luer-formatted disinfection cap
ClearGuard HD end caps are blood access device accessories. The ClearGuard Hemodialysis (HD) end cap is a male luer lock end cap with the antimicrobial agent chlorhexidine acetate on the rod and lock ring threads. Each package contains two ClearGuard HD end caps assembled in a shield. The total amount of chlorhexidine acetate on a pair of devices is not more than 2.4 mg, and the maximum amount that is available to be released to the patient is 0.6 mg per device pair. The ClearGuard HD end caps can be used for up to a maximum of 72 hours. ClearGuard HD is indicated for use as an end cap for use with hemodialysis catheter hubs.The antimicrobial treatment on the ClearGuard HD end cap has been shown to be effective at reducing microbial colonization in hemodialysis catheter hubs against the following microorganisms: Enterococcus faecium (VRE), Enterococcus faecalis (VRE), Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus (MRSA), Staphylococcus aureus, Staphylococcus epidermidis (MRSE), Pseudomonas aeruginosa, Candida albicans and Candida parapsilosis and has not been shown to be effective against Candida paratropicalis and Klebsiella pneumoniae. The antimicrobial effectiveness was evaluated using in vitro methods, and correlation between in vitro antibacterial activity and any clinical effectiveness has not been tested. The subject device is not intended to be used for the treatment of existing infections. The antimicrobial is only effective within the hub of the catheter, and does not migrate to distal portions of the catheter.
Pursuit Vascular, Inc.
CGHD
Not in Commercial Distribution

  • B081CGHD110236861 ()


  • Luer-formatted disinfection cap
ClearGuard HD end caps are blood access device accessories. The ClearGuard Hemodialysis (HD) end cap is a male luer lock end cap with the antimicrobial agent chlorhexidine acetate on the rod and lock ring threads. Each package contains two ClearGuard HD end caps assembled in a shield. The total amount of chlorhexidine acetate on a pair of devices is not more than 2.4 mg, and the maximum amount that is available to be released to the patient is 0.6 mg per device pair. The ClearGuard HD end caps can be used for up to a maximum of 72 hours. ClearGuard HD is indicated for use as an end cap for use with hemodialysis catheter hubs.The antimicrobial treatment on the ClearGuard HD end cap has been shown to be effective at reducing microbial colonization in hemodialysis catheter hubs against the following microorganisms: Enterococcus faecium (VRE), Enterococcus faecalis (VRE), Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus (MRSA), Staphylococcus aureus, Staphylococcus epidermidis (MRSE), Pseudomonas aeruginosa, Candida albicans and Candida parapsilosis and has not been shown to be effective against Candida paratropicalis and Klebsiella pneumoniae. The antimicrobial effectiveness was evaluated using in vitro methods, and correlation between in vitro antibacterial activity and any clinical effectiveness has not been tested. The subject device is not intended to be used for the treatment of existing infections. The antimicrobial is only effective within the hub of the catheter, and does not migrate to distal portions of the catheter.
Pursuit Vascular, Inc.
CGHD
Not in Commercial Distribution

  • B081CGHD110236860 ()


  • Luer-formatted disinfection cap
ClearGuard HD end caps are blood access device accessories. The ClearGuard Hemodialysis (HD) end cap is a male luer lock end cap with the antimicrobial agent chlorhexidine acetate on the rod and lock ring threads. Each package contains two ClearGuard HD end caps assembled in a shield. The total amount of chlorhexidine acetate on a pair of devices is not more than 2.4 mg, and the maximum amount that is available to be released to the patient is 0.6 mg per device pair. The ClearGuard HD end caps can be used for up to a maximum of 72 hours. ClearGuard HD is indicated for use as an end cap for use with hemodialysis catheter hubs.The antimicrobial treatment on the ClearGuard HD end cap has been shown to be effective at reducing microbial colonization in hemodialysis catheter hubs against the following microorganisms: Enterococcus faecium (VRE), Enterococcus faecalis (VRE), Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus (MRSA), Staphylococcus aureus, Staphylococcus epidermidis (MRSE), Pseudomonas aeruginosa, Candida albicans and Candida parapsilosis and has not been shown to be effective against Candida paratropicalis and Klebsiella pneumoniae. The antimicrobial effectiveness was evaluated using in vitro methods, and correlation between in vitro antibacterial activity and any clinical effectiveness has not been tested. The subject device is not intended to be used for the treatment of existing infections. The antimicrobial is only effective within the hub of the catheter, and does not migrate to distal portions of the catheter.
Pursuit Vascular, Inc.
CGHD
Not in Commercial Distribution

  • B081CGHD110236859 ()


  • Luer-formatted disinfection cap
< 1 ... 9 10 11 12 13 ... 44 >